Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iguratimod in active lupus nephritis (IGeLU)
NCT02936375Phase 2Unknown
- Sponsor
- Renji Hospital
- Start
- Sep 2017
- Primary completion
- Nov 2020
- Countries
- 1
01
Overview
A Phase 2 trial of iguratimod in lupus nephritis (LN), sponsored by Renji Hospital. Status: unknown.
02
Drugs
iguratimod
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT02936375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02936375.